Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 14th July 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zoetis found in breach of NOAH medicines promotion code
NOAH has ruled that Zoetis UK Limited has breached its Code of Practice for the Promotion of Animal Medicines.

The case involved unsubstantiated claims about CircoMax® Myco. 

The National Office of Animal Health (NOAH) has ruled that Zoetis UK Limited has breached its Code of Practice for the Promotion of Animal Medicines.

NOAH’s Code of Practice on the Promotion of Animal Medicines Committee met in June 2021 to discuss a case brought about by Hipra UK and Ireland Ltd. The case involved promotional claims made between March and May 2021 for Zoetis’ product, CircoMax® Myco.

Hipra UK and Ireland Ltd complained that Zoetis had made unsubstantiated claims that CircoMax® Myco provides the broadest protection and broader coverage against porcine circovirus (PCV2).

Among these claims included the phrases: “Stay one step ahead with the broadest, longest-lasting combined PCV2 and M.hyo* protection” and “Protect your pigs with Europe’s first and only dual PCV2 genotype vaccine. Broader coverage – against multiple PCV2 genotype and Mycoplasma hyopneumoniae”.

A NOAH press release reads: ‘Following comprehensive presentations from both parties and detailed analysis of the scientific and technical background, the Committee found that in their promotional statements, Zoetis promoted its CircoMax® Myco vaccine as providing better and broader protection against the PCV2 virus than other vaccines on the market and that the evidence presented was not sufficient to substantiate such claims.'

Further details about the case are available on the NOAH website.

 

Become a member or log in to add this story to your CPD history

VMD invites students to apply for EMS placement

News Story 1
 The Veterinary Medicines Directorate (VMD) is inviting applications from veterinary students to attend a one-week extramural studies (EMS) placement in July 2026.

Students in their clinical years of study have until 28 February to apply for the placement, which takes place at the VMD's offices in Addlestone, Surrey, from 6-10 July 2026.

Through a mixture of lectures and workshops, the placement will explore how veterinary medicines are authorised, non-clinical career opportunities, and other important aspects of the VMD's work.  

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk